Dr Rahul Kumar, MD, PHD | |
200 1st St Sw, Rochester, MN 55905-0001 | |
(507) 284-2511 | |
Not Available |
Full Name | Dr Rahul Kumar |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 200 1st St Sw, Rochester, Minnesota |
Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003449000 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 31569 (Minnesota) | Secondary |
207T00000X | Neurological Surgery | 72374 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Rahul Kumar, MD, PHD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 | Dr Rahul Kumar, MD, PHD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 |
News Archive
ABC reports that although nonprofit hospitals are obligated to give back to the community, they often don't ease the strain for patients with financial difficulties. And in other news, The New York Times looks at efforts to cut emergency room care costs.
Scientists at the University of Surrey and University College London have revealed an innovative in vitro method that can help to develop easy to swallow medicine for children and older people.
Policymakers and developers planning high-density housing near public transit with the goal of reducing automobile use and greenhouse gas emissions that contribute to global warming need a clearer understanding of the health risks from air pollution that may be created if that housing is also built near busy roads and freeways, according to new research by Keck School of Medicine of the University of Southern California scientists.
Alkermes, Inc. today announced positive topline data from a phase 1 clinical study of ALKS 37, an orally active, peripherally-restricted opioid antagonist with potential to block the effects of opioid agonists on gastrointestinal motility, commonly referred to as opioid-induced constipation (OIC).
InSightec Ltd, the global leader in MR guided Focused Ultrasound (MRgFUS), announced that it has received approval from the US Food and Drug Administration to begin a Phase I clinical trial evaluating the use of its ExAblate Neuro system for the treatment of patients with tremor dominant Parkinson's Disease.
› Verified 8 days ago
Dr. Jennifer Lee Perez, MD, PHD Neurological Surgery Medicare: May Accept Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Fredric B Meyer, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Robert J Spinner, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Hirotaka Hasegawa, Neurological Surgery Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Noor Malik, MBBS Neurological Surgery Medicare: Medicare Enrolled Practice Location: 200 First Street Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Archis Ramkrishna Bhandarkar, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 |